drugset / Trial / NCT01645761

Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori

NCT01645761

Completed 112 enrolled Chuncheon Sacred Heart Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Endonase, a kind of protease, is known to cause both extensive degradation of mucins and a reduction in mucus viscosity. As part of the search for more effective forms of therapy against H. pylori when it colonizes not only the surface of the surface mucosal cells but also the surface mucous gel layer covering the mucosal surface of the stomach. The investigators decided to investigate whether or not endonase might have additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.

Timeline

Start
2012-06
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject pronase Protein / enzyme biologic 20000 iu

Indications